A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

NCT01357668 ·Status: ACTIVE_NOT_RECRUITING

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

NCT00767325 ·Status: COMPLETED ·Phase: PHASE3

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan

NCT02335606 ·Status: COMPLETED

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

NCT00989235 ·Status: COMPLETED ·Phase: PHASE3

Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)

NCT03492658 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate

NCT00619905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

NCT03414502 ·Status: RECRUITING ·Phase: PHASE3

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept

NCT01221636 ·Status: WITHDRAWN ·Phase: PHASE1

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis

NCT01299961 ·Status: COMPLETED ·Phase: PHASE3

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

NCT02632890 ·Status: COMPLETED

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

Observational Trial With Enbrel

NCT00488475 ·Status: COMPLETED

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

NCT05421442 ·Status: COMPLETED

Remission Induction in Very Early Rheumatoid Arthritis

NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment

NCT00902005 ·Status: COMPLETED

Rheumatology Biorepository

NCT04899895 ·Status: ENROLLING_BY_INVITATION

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

NCT00558506 ·Status: UNKNOWN ·Phase: PHASE2

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

NCT05375942 ·Status: COMPLETED

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

NCT00796705 ·Status: TERMINATED ·Phase: PHASE4

Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

NCT01166620 ·Status: COMPLETED